Algernon Announces First U.S. Clinical Trial Site in Florida for Phase 2b/3 Human Study of Ifenpro..
Algernon Announces First U.S. Clinical Trial Site in Florida for Phase 2b/3 Human Study of Ifenprodil for COVID-19 VANCOUVER, British...
© 2023 Frontier Merchant Capital Group. All Rights Reserved.